Name | Number of supported studies | Average coverage | |
---|---|---|---|
non-classical monocyte | 9 studies | 24% ± 7% | |
classical monocyte | 8 studies | 25% ± 6% | |
conventional dendritic cell | 6 studies | 25% ± 11% | |
macrophage | 6 studies | 19% ± 3% | |
dendritic cell | 5 studies | 32% ± 14% | |
myeloid cell | 3 studies | 17% ± 1% | |
intermediate monocyte | 3 studies | 23% ± 7% |
Insufficient scRNA-seq data for expression of IRF5 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
kidney | 100% | 1865.81 | 89 / 89 | 96% | 22.00 | 869 / 901 |
lung | 100% | 1839.57 | 576 / 578 | 96% | 16.97 | 1112 / 1155 |
pancreas | 98% | 479.54 | 321 / 328 | 98% | 15.38 | 174 / 178 |
bladder | 95% | 687.71 | 20 / 21 | 96% | 23.32 | 485 / 504 |
breast | 93% | 508.80 | 429 / 459 | 98% | 11.18 | 1091 / 1118 |
liver | 96% | 445.93 | 218 / 226 | 91% | 8.13 | 368 / 406 |
esophagus | 92% | 856.02 | 1326 / 1445 | 95% | 11.26 | 173 / 183 |
stomach | 93% | 379.49 | 334 / 359 | 92% | 8.71 | 264 / 286 |
intestine | 95% | 761.55 | 914 / 966 | 90% | 8.55 | 473 / 527 |
thymus | 89% | 371.79 | 578 / 653 | 95% | 10.79 | 574 / 605 |
prostate | 96% | 554.62 | 236 / 245 | 85% | 5.31 | 426 / 502 |
brain | 74% | 324.22 | 1965 / 2642 | 93% | 11.38 | 657 / 705 |
uterus | 69% | 225.69 | 117 / 170 | 93% | 23.16 | 428 / 459 |
skin | 72% | 781.95 | 1303 / 1809 | 84% | 9.22 | 397 / 472 |
adrenal gland | 95% | 581.81 | 245 / 258 | 59% | 3.46 | 136 / 230 |
ovary | 33% | 97.39 | 59 / 180 | 97% | 12.03 | 415 / 430 |
lymph node | 0% | 0 | 0 / 0 | 100% | 58.40 | 29 / 29 |
spleen | 100% | 3881.52 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 19.02 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 14.04 | 1 / 1 |
peripheral blood | 100% | 4335.93 | 928 / 929 | 0% | 0 | 0 / 0 |
adipose | 97% | 817.65 | 1171 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 75% | 416.20 | 996 / 1335 | 0% | 0 | 0 / 0 |
heart | 42% | 140.15 | 363 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 40% | 2.24 | 32 / 80 |
muscle | 6% | 16.75 | 52 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0019221 | Biological process | cytokine-mediated signaling pathway |
GO_0002376 | Biological process | immune system process |
GO_0032728 | Biological process | positive regulation of interferon-beta production |
GO_0006954 | Biological process | inflammatory response |
GO_0045087 | Biological process | innate immune response |
GO_0002720 | Biological process | positive regulation of cytokine production involved in immune response |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0032495 | Biological process | response to muramyl dipeptide |
GO_0051607 | Biological process | defense response to virus |
GO_0032735 | Biological process | positive regulation of interleukin-12 production |
GO_0032481 | Biological process | positive regulation of type I interferon production |
GO_0032727 | Biological process | positive regulation of interferon-alpha production |
GO_0032494 | Biological process | response to peptidoglycan |
GO_0098586 | Biological process | cellular response to virus |
GO_0043065 | Biological process | positive regulation of apoptotic process |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0043565 | Molecular function | sequence-specific DNA binding |
GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
GO_0019901 | Molecular function | protein kinase binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0005515 | Molecular function | protein binding |
Gene name | IRF5 |
Protein name | Interferon regulatory factor 5 transcript variant 13 Interferon regulatory factor 5 transcript variant 17 Interferon regulatory factor 5 transcript variant 15 Interferon regulatory factor 5 variant 9 Interferon regulatory factor 5 Interferon regulatory factor 5 variant 7 Interferon regulatory factor 5 (IRF-5) Interferon regulatory factor 5 transcript variant 14 Interferon regulatory factor 5 transcript variant 16 |
Synonyms | |
Description | FUNCTION: Transcription factor that plays a critical role in innate immunity by activating expression of type I interferon (IFN) IFNA and INFB and inflammatory cytokines downstream of endolysosomal toll-like receptors TLR7, TLR8 and TLR9 . Regulates the transcription of type I IFN genes (IFN-alpha and IFN-beta) and IFN-stimulated genes (ISG) by binding to an interferon-stimulated response element (ISRE) in their promoters (By similarity). Can efficiently activate both the IFN-beta (IFNB) and the IFN-alpha (IFNA) genes and mediate their induction downstream of the TLR-activated, MyD88-dependent pathway (By similarity). Key transcription factor regulating the IFN response during SARS-CoV-2 infection . . |
Accessions | ENST00000473745.5 [Q13568-1] A0A0G2USB5 A0A0G2UM11 A0A0G2UUJ1 F8WDH6 ENST00000357234.10 [Q13568-2] ENST00000700149.1 C9JB67 Q13568 ENST00000473787.5 I6ZU14 C9JYP7 ENST00000402030.6 [Q13568-1] I6YQ35 C9J7M2 ENST00000489702.6 [Q13568-2] Q64GB0 I6Z0J2 ENST00000700150.1 I6ZY36 Q64GA8 ENST00000465603.5 [Q13568-6] I6ZKX6 ENST00000477535.5 [Q13568-5] ENST00000464557.5 ENST00000479582.5 ENST00000467002.1 ENST00000652525.1 |